Yusuf TUTAR PhD
Prof, Recep Tayyip Erdoğan University, Rize, Rize Province · Turkey
Editorial leadership for International Journal of Translational Research
Research interests
- Molecular Cancer Research
- Epigenetic (Rt-Pcr
- Microarray). Microrna
- Pseudogenes
- And Transfection. Prion
- Translation Termination In Eukaryotes
- And Transcription Initiation In Prokaryotes. Investigating Structure-Function Relationship Of Biological Macromolecules With Biochemical
- Biophysical
- Genetics
- Molecular Biological Methods. Recombinant Dna Technology
- Molecular Sub-Cloning
- Transformation
- Protein Expression. Drug Design
- Docking
- Molecular Dynamics. Nanoparticles For Drug Targeting. Protein Purification (Heat Shock
- Catabolite Repressor
- S100P Proteins)
- Characterisation (Spectroscopy: Fluorescence
- Luminescence
- Cd
- Ftir; Calorimetry: Nanodsc
- Itc; Chromatography: Hplc
- Fplc; Other Techniques: Maldi-Tof
- Gc
- Spr)
Biography
Prof. Yusuf Tutar is a faculty member at Recep Tayyip Erdoğan University in Rize, Turkey, where his research focuses on biochemistry, biophysics, genetics, and molecular biology with specialization in protein structure-function, protein folding, prion biology, microRNA, pseudogenes, molecular cancer, proteomics, and genomics. He obtained his M.Sc. at Oregon State University and his Ph.D. at Texas Tech University, followed by postdoctoral training at the National Institutes of Health (NIH/NIDDK) in the United States. His work emphasizes protein expression and characterization using spectroscopic and calorimetric methods. Prof. Tutar has authored over 36 indexed publications, including his most-cited work on capecitabine in novel combination therapies for colorectal cancer (2021).
Selected publications
- Performance of capecitabine in novel combination therapies in colorectal cancer 2021 cited 17×
- Triad pyrazole–thiazole–coumarin heterocyclic core effectively inhibit HSP and drive cancer cells to apoptosis 2023 cited 14×
- Perturbation of HSP Network in MCF-7 Breast Cancer Cell Line Triggers Inducible HSP70 Expression and Leads to Tumor Suppression 2020 cited 13×
- Designing Specific HSP70 Substrate Binding Domain Inhibitor for Perturbing Protein Folding Pathways to Inhibit Cancer Mechanism 2021 cited 8×
- Non-genetic heterogeneity and immune subtyping in breast cancer: Implications for immunotherapy and targeted therapeutics 2024 cited 8×
- In Vitro Effects of Rumex confertus Extracts on Cell Viability and Molecular Pathways in MCF-7 Breast Cancer Cells Recent 2025 cited 6×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJTR for your work?
This journal is guided by Yusuf TUTAR (Prof, Recep Tayyip Erdoğan University, Rize, Rize Province) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.